Tissue Repair: The Hidden Drama
Tissue Repair: The Hidden Drama
Tissue Repair: The Hidden Drama
Tissue repair
The hidden drama
Kristine P. Krafts
Department of Pathology; University of Minnesota School of Medicine; Duluth Campus; Duluth, MN USA
Key words: tissue repair, regeneration, scarring, wound healing, growth factors, extracellular matrix, stem cells
Abbreviations: cAMP, 3', 5' cyclic adenosine monophosphate; CDK, cyclin-dependent protein; DNA, deoxyribonucleic acid;
ECM, extracellular matrix; EGF, epidermal growth factor; FGF, fibroblast growth factor; GAG, glycosaminoglycan; KGF,
keratinocyte growth factor; MAD, mothers against decapentaplegic; MMP, matrix metalloproteinase; IL, interleukin; JAK, janus
kinase; OPN, osteopontin; PDGF, platelet-derived growth factor; RB, retinoblastoma; STAT, signal transducer and activator of
transcription; TGF, transforming growth factor; TIMP, tissue inhibitor of metalloproteinases; TNF, tumor necrosis factor; VEGF,
vascular endothelial growth factor
activins, inhibins and Mllerian inhibiting substance.4 Made of new chemotherapeutic agents.11 Other growth factors include
by platelets, endothelial cells, lymphocytes and macrophages, epidermal growth factor (EGF) and hepatocyte growth factor
TGF- binds to cell-surface receptors that have serine/threonine (HGF). Both stimulate epithelial cell and hepatocyte prolifera-
kinase activity, triggering phosphorylation of cytoplasmic tran- tion and enhance epithelial cell migration. Once known as the
scription factors called Smads, so-named for the two drosophilia scatter factor, HGF also promotes cell scattering during embry-
proteins of which they are homologs: the mothers against deca- onic development.12
pentaplegic (MAD) and Caenorhabeitis elegans proteins.5 Smads In addition to growth factors, cytokines also carry impor-
then enter the nucleus and affect gene transcription. tant messages between cells during tissue repair. Small proteins
Although TGF- has many functions, its most important secreted by cells of the immune system, cytokines are perhaps
role in tissue repair is to promote fibrosis, a feat it accomplishes best known for their role as immunomodulators within both
by: (1) attracting fibroblasts and stimulating them to proliferate, the cellular and humoral arms of the adaptive immune system.
(2) triggering fibroblasts to secrete collagen and (3) inhibiting Three cytokines in particular are involved in tissue repair: tumor
extracellular matrix degradation by metalloproteinases. Not sur- necrosis factor (TNF) and interleukin-1 (IL-1) participate in the
prisingly, TGF- is a key factor in conditions involving patho- wound healing stage of tissue repair and TNF and interleukin-6
logic fibrosis, such as pulmonary fibrosis, systemic sclerosis and (IL-6) are involved in liver regeneration.13
Marfan syndrome.6 In addition to its fibrogenic effects, TGF- Receptor-mediated signaling. For humans, words must be
also inhibits epithelial cell growth, diminishes inflammation and seen or heard to have meaning. So it is with the messages between
promotes invasion and metastasis in tumors.7 cells in the tissue repair drama: the growth factor or cytokine
Another essential, multitasking growth factor is platelet- message must have a way to get into the target cell for action to
derived growth factor (PDGF), so named because it is stored in take place. This process is termed receptor-mediated signal trans-
platelet granules and released upon platelet activation. Made by duction and it involves binding of a ligand (a growth receptor or
a number of cells including macrophages, endothelial cells and cytokine) to a receptor molecule on a target cell. This binding
smooth muscle cells, PDGF is involved in nearly every aspect of triggers events that transduce the signal from the outside of the
tissue repair. It calls neutrophils, macrophages and fibroblasts to cell to the inside. The end result is a change in gene expression,
the wound area and subsequently stimulates and activates them. for example, transcription of genes that normally may be silent,
It also induces angiogenesis, triggers production of matrix metal- such as those that control cell cycle entry.
loproteinases (MMPs), fibronectin and hyaluronic acid and aids Receptor-mediated signaling often occurs between cells adja-
in wound contraction.8 cent to one another (paracrine signaling); for example, macro-
Fibroblast growth factor (FGF) calls virtually all of the major phages produce growth factors that bind to receptors on adjacent
players (macrophages, fibroblasts and endothelial cells) to the fibroblasts. However, signaling can also occur between cells
scene of the wound. It initiates the migration of epithelial cells located at some distance from each other (endocrine signal-
in from the margins of the wound, mediates wound contraction ing), as is often the case with cytokines and their distant targets.
and stimulates angiogenesis.9 Contrary to what one might infer Signaling may even occur within the same cell (autocrine signal-
from its name, however, FGF does not stimulate collagen synthe- ing), as when a tumor cell overproduces both a growth factor and
sis. The more appropriately-named vascular endothelial growth its receptor, which interact and lead to unbridled cell growth.
factor (VEGF) acts primarily on endothelial cells. It is a potent Whatever the mode of signaling may be, there are four main
inducer of blood vessel formation in tissue repair as well as in early types of receptors: those with intrinsic tyrosine kinase activ-
fetal development.10 Overexpressed in certain tumors, particu- ity, those without intrinsic tyrosine kinase activity, G protein-
larly renal cell carcinoma, VEGF is a target for the development coupled receptors and steroid hormone receptors. Receptors with
drama as it occurs in first intention wounds, noting second inten- scattered fibroblasts. Initially, the new vessels are leaky and the
tion differences where necessary. granulation tissue has an edematous, loose appearance (Fig. 1).
Act I: inflammation. Immediately after the wound is inflicted, As the vessels grow stronger and fibroblasts begin to lay down
the most urgent task is not to repair the damaged tissue, but to collagen, it takes on a more substantial appearance, reaching its
stop the flow of blood from the wound. Within seconds of the maximum vascularity by day 5.1
injury, exposed collagen activates coagulation in the region of the Macrophageslarge, multitasking cells derived from mono-
injury. Platelets form an initial plug, coagulation cascade factors cytesnow replace the neutrophils that were so numerous in the
interact to form fibrin (which seals and solidifies the plug) and a immediate aftermath of the wounding. As their name suggests,
blood clot soon appears at the skin surface. Not only does the clot a primary function of macrophages is the ingestion of unwanted
stop the bleeding, but it serves as a scaffold for incoming cells and materials: bacteria, cell remnants, debris, fibrin and foreign mate-
a repository of cytokines and growth factors.22,23 rial. But macrophages also serve as directors for many other parts
At the skin surface, all appears static and calm as the clot of the drama. They call in and stimulate fibroblasts and kera-
dries and forms a scab. Underneath the surface, however, a tinocytes (through release of PDGF, TGF-, TNF, IL-1 and
flurry of activity begins. An army of neutrophils rushes to the KGF), stimulate angiogenesis (by secretion of VEGF, FGF and
scene through dilated local blood vessels, called to the area by PDGF) and direct the laying down and remodeling of extracel-
IL-1, TNF, TGF- and other growth factors. Within 24 hours, lular matrix [through the use of TGF-, PDGF, tumor necrosis
the neutrophils appear at the edges of the wound incision, using factor (TNF), osteopontin (OPN), IL-1, collagenase and matrix
the fibrin scaffolding of the clot to invade the region of destruc- metalloproteinases (MMPs)].22
tion, their primary tasks being to break down debris and kill The formation of new blood vessels (angiogenesis) begins
bacteria. within the first few days following injury, aided by VEGF and
Epithelial cells, meanwhile, begin their arduous process of FGF.27 The process is unexpectedly aided by a small number of
repair by crawling from the basal layers of the epidermis into the bone-marrow-derived endothelial precursor cells which home
wounded region, depositing basement membrane components to the wound by mysterious mechanisms. Their contribution to
as they migrate. They are called to begin this process by EGF the overall angiogenesis effort, however, is minimal.28 Formation
and TGF-a, secreted by activated platelets and macrophages. In of the correct blood vessel structure is aided by integrins on the
addition, fibroblasts secrete KGF (keratinocyte growth factor) surface of endothelial cells; surrounding perithelial cells are
and IL-6, factors that enhance keratinocyte migration and pro- recruited with the help of angiopoietin.
liferation.24,25 Fusing in the midline underneath the inert scab, The end point toward which the entire drama is directed is
these epithelial cell pioneers form the first thin, continuous layer the formation of a scar, a strong collagen filler that bridges the
of epithelium upon which the rest of the new epithelium will be gap left by tissue destruction, restoring strength and integrity to
built.26 the tissue. This process begins with the entrance of the fibroblast
Act II: proliferation. Following the initial flurry of clotting between days one and three, called to action by many growth fac-
and neutrophil activity, the work of cell proliferation begins in tors and cytokines, including PDGF, EGF and TGF-. At first,
earnest. The characteristic feature of this act in the drama is the type III collagen secreted by fibroblasts is arrayed vertically
the formation of a substance called granulation tissue, a pink, at the margins of the incision. Later, the collagen combines with
soft material so-named for its irregular, grainy appearance. fibrin and plasma fibronectin (which deposition is promoted by
Consisting of new blood vessels and fibroblasts in an extracel- the vascular permeability inherent in angiogenesis); this provi-
lular matrix, granulation tissue is laid down over a period of a sional matrix provides a framework for further fibroblast and
few days, beginning with a few small, tenuous blood vessels and endothelial cell ingrowth (Fig. 2).29
By day 3 to day 5, ECM formation is well underway, with down by a family of enzymes known as tissue inhibitors of metal-
granulation tissue serving as a substrate (Fig. 3). Shards of elas- loproteinases (TIMPs). Produced by mesenchymal cells, TIMPs
tic tissue form within the wound site. Plump fibroblasts mature help reign in collagen (and other ECM component) breakdown
into thin, spindle-shaped fibrocytes, which become entrapped in so that scar formation can proceed.
the dense, fibrillar collagen they have secreted (Fig. 4). Collagen Ultimately, strength is achieved by increased collagen synthe-
deposition is a balance between synthesis and degradation. In sis, followed by post-synthetic modifications of collagen, includ-
these early stages, the balance tips toward collagen synthesis, ing cross-linking and increased fiber size. Early in wound healing,
aided by TGF-, which inhibits the degradation of collagen. The the collagen is relatively thin and oriented parallel to the skin;
process of ECM deposition ends within 23 weeks. over time, the initial collagen fibrils are resorbed and replaced
Meanwhile, the epithelium quietly continues to proliferate. with thicker fibrils aligned with stress lines.22 Wound strength
Mediated by the aforementioned KGF and IL-6, it increases in increases rapidly during the first month, then slows, reaching a
thickness, eventually regaining its full, stratified architecture and plateau of 7080% of the original tensile strength by the end of
keratinized surface some time between 1 and 3 weeks (or later in the third month. Although full-thickness epithelial regeneration
second-intention healing).27 is possible, any skin appendages lost during the initial injury will
Act III: maturation. During the second week following the not be reformed.
incision, leukocytes gradually abandon the wound area and ves- Given their easily-approximated margins, wounds healing by
sels recede (Fig. 5). Type I collagen synthesis increases, due to first intention generally have minimal scarring. Wounds healing
both an increased number of fibroblasts and an increased rate of by second intention, however, are larger, with more epithelial
synthesis per fibroblast.30 Where there was once granulation tis- destruction, necessitating more collagen deposition to close the
sue, there is now a preliminary scar, pale and firm, composed of wound. The process of wound contraction eases the fibroblasts
dense collagen, fibroblasts and shards of elastic tissue. In another burden a bit. Specialized contractile, smooth-muscle-like cells
two weeks, even the fibroblasts begin to disappear and eventu- called myofibroblasts appear within the wound and pull the mar-
ally an acellular scar bridges the region of the wound, covered gins of the wound toward each other. These cells may be derived
by intact, fully-developed epidermis. Dermal appendages in the from tissue fibroblasts under the influence of FGF and PDGF;
region of the wound, however, are not reformed. they may also develop from epithelial cells or from bone marrow
Over the next several weeks, the composition of the extracel- precursor cells called fibrocytes. So efficient are these myofibro-
lular matrix changes, remodeling the newly-formed scar such that blasts that large wounds may decrease in size by up to 80%.32
it attains maximal strength at an appropriate size. Although sev- When the drama ends badly. Several systemic factors may
eral serine protease enzymes (such as neutrophil elastase, cathep- adversely affect the performance of the tissue repair drama.
sin G, kinins and plasmin) operate in the remodeling process, Patients with diabetes mellitus tend to have less granulation tis-
the key mediators of remodeling are zinc-dependent proteases sue formation, less collagen deposition and defects in collagen
known as matrix metalloproteinases (MMPs).31 There are many maturation, leading to slow and ineffective wound maturation.33
different types of MMPs, including collagenases (which cleave While this predisposition has been attributed to the microangi-
fibrillar collagen), gelatinases (which act on amorphous collagen opathy inherent in diabetes, recent research indicates that other
and fibronectin) and stromelysins (which degrade a number of factors, such as collagen glycosylation and pericapillary albumin
ECM components including laminin, fibronectin, proteogly- deposition, may play a role.22,34 Poor nutrition also retards the
cans and amorphous collagen). MMPs are produced by many healing process. Vitamin C, in particular, is necessary for col-
different types of cells, including fibroblasts and macrophages; lagen synthesis. Deprivation of this vitamin results in failure of
their secretion is stimulated by PDGF and FGF and inhibited activation of proline and lysine hydroxylases and formation of
by TGF-. Once they are produced, MMPs are rapidly broken unhydroxylated procollagen peptides, resulting in an unstable,
References 13. Fedyk ER, Jones D, Critchley HO, Phipps RP, Blieden 26. Lawrence WT, Diegelmann RF. Growth factors in
TM, Springer TA. Expression of stromal-derived fac- wound healing. Clin Dermatol 1994; 12:157-69.
1. Kumar V, Abbas AK, Fausto N, Aster JC. Tissue tor-1 is decreased by IL-1 and TNF and in dermal 27. Werner S, Grose R. Regulation of wound healing
renewal, regeneration and repair. In: Robbins and wound healing. J Immunol 2001; 166:5749-54. by growth factors and cytokines. Physiol Rev 2003;
Cotran, eds. Pathologic Basis of Disease. Eighth ed. 14. Robinson DR, Wu YM, Lin SF. The protein tyrosine 83:835-70.
Philadelphia: Elsevier 2010; 79-110. kinase family of the human genome. Oncogene 2000; 28. Bluff J, Ferguson M, OKane S, Ireland G. Bone
2. Conover JC, Notti RQ. The neural stem cell niche. Cell 19:5548-57. marrow-derived endothelial progenitor cells do not
Tissue Res 2008; 331:211-24. 15. Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT contribute significantly to new vessels during incisional
3. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry W, signaling pathway. J Cell Science 2004; 117:1281-3. wound healing. Exp Hematol 2007; 35:500-6.
Rendl M, et al. Defining the epithelial stem cell niche 16. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen 29. Pierce GF, Mustoe TA, Altrock BW, Deuel TF,
in skin. Science 2004; 303:359-63. SG, Thian FS, Kobilka TS, et al. High-resolution crys- Thomason A. Role of platelet-derived growth factor in
4. Bessa PC, Casal M, Reis RL. Bone morphogenetic pro- tal structure of an engineered human 2-adrenergic G wound healing. J Cell Biochem 2004; 45:319-26.
teins in tissue engineering: the road from laboratory to protein-coupled receptor. Science 2007; 318:1258-65. 30. Diegelmann R. Analysis of collagen synthesis. Methods
the clinic. Part 1-basic concepts. J Tiss Eng Regen Med 17. Nigg EA. Cyclin-dependent protein kinases: key regu- Mol Med 2003; 78:349-58.
2008; 2:1-13. lators of the eukaryotic cell cycle. Bioessays 1995; 31. Pilcher BK, Wang M, Qin X, Parks WC, Senior RM,
5. Itoh F, Asao H, Sugamura K, Heldin CH, ten Dijke P, 17:471-80. Welgus HG. Role of matrix metalloproteinases and
Itoh S. Promoting bone morphogenetic protein signal- 18. Mnger K, Howley PM. Human papillomavirus their inhibition in cutaneous wound healing and aller-
ing through negative regulation of inhibitory Smads. immortalization and transformation functions. Virus gic contact hypersensitivity. Ann NY Acad Sci 2006;
EMBO J 2001; 20:4132-42. Res 2002; 89:213-28. 878:12-24.
6. Horan GS, Wood S, Ona V, Li DJ, Lukashev ME, 19. Hynes RO. Integrins: bidirectional, allosteric signaling 32. Lorentz HP, Longaker MT. Wounds: Biology, pathol-
Weinreb PH, et al. Partial inhibition of integrin machines. Cell 2002; 110:673-87. ogy and management. In: Norton JA, Barie PS,
v prevents pulmonary fibrosis without exacerbat- Bollinger RR, Chang AE, Lowry S, Mulvihill SJ, et al.
20. Apte U, Singh S, Zeng G, Cieply B, Virji MA, Wu T,
ing inflammation. Am J Resp Crit Care Med 2008; Eds. Surgery: Basic science and clinical evidence. 2nd
et al. Beta-catenin activation promotes liver regenera-
177:56-65. edition. New York: Springer 2008; 191-208.
tion after acetaminophen-induced injury. Am J Pathol
7. Attisano L, Wrana JL. Signal transduction by the 2009; 175:1056-65. 33. Chow LW, Loo WT, Yuen KY, Cheng C. The study of
TGFbeta superfamily. Science 2002; 296:1646-7. cytokine dynamics at the operation site after mastec-
21. Rafii S, Lyden D. Therapeutic stem and progenitor cell
8. Andrae J, Gallini R, Betsholtz C. Role of platelet- transplantation for organ vascularization and regenera- tomy. Wound Repair Regen 2003; 11:326-30.
derived growth factors in physiology and medicine. tion. Nat Med 2003; 9:702-12. 34. Bucalo B, Eaglstein WH, Falanga V. Inhibition of cell
Genes Dev 2008; 22:1276-312. proliferation by chronic wound fluid. Wound Rep
22. Broughton G, Janis JE, Attinger CE. Wound healing:
9. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post An overview. Plast Reconstr Surg 2006; 117:1-32. Regen 2002; 1:181-6.
MJ, Wahlberg E, et al. Angiogenic synergism, vascular 35. Robson MC. Wound infection: A failure of wound
23. Witte MB, Barbul A. General principles of wound
stability and improvement of hind-limb ischemia by a healing caused by an imbalance of bacteria. Surg Clin
healing. Surg Clin North Am 1997; 77:509-28.
combination of PDGF-BB and FGF-2. Nat Med 2003; North Am 1997; 77:637-50.
9:604-13. 24. Smola H, Thiektter, Fusenig NE. Mutual induction
of growth factor gene expression by epidermal-dermal 36. Dabiri G, Tumbarello DA, Turner CE, Van De Water
10. Holmes K, Roberts OL, Thomas AM, Cross MJ. L. Hic-5 promotes the hypertrophic scar myofibroblast
interaction. J Cell Biol 1993; 122:417-29.
Vascular endothelial growth factor receptor-2: phenotype by regulating the TGF-1 autocrine loop. J
Structure, function, intracellular signaling and thera- 25. Xia YP, Zhao Y, Marcus J, Jiminez PA, Ruben SM,
Moore PA, et al. Effects of keratinocyte growth factor-2 Invest Dermatol 2008; 128:2518-25.
peutic inhibition. Cell Signal 2007; 19:2003-12.
(KGF-2) on wound healing in an ischaemia-impaired
11. Escudier B. Anti-VEGF therapy for renal cell carci-
rabbit ear model and on scar formation. J Pathol 1999;
noma. Clin Adv Hematol Oncol 2007; 5:530-1.
188:431-8.
12. Schmidt C, Bladt F, Goedecke S, Brinkmann V,
Zschiesche W, Sharpe M, et al. Scatter factor/hepato-
cyte growth factor is essential for liver development.
Nature 1995; 373:699-702.